ArticleScientific reports2025
Vector competence of mosquitoes from Europe for Tahyna virus.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pharmacological targeting of bunyavirus-induced synaptic impairment prevents neuronal hyperexcitability.Nature communications · 2026Article
- First molecular evidence and phylogenetic characterization of Aedes (Hulecoeteomyia) koreicus (Diptera: Culicidae) in Slovakia.Parasitology research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tahyna virus (TAHV) was the first mosquito-borne virus isolated in Europe, and has since been found throughout Eurasia and Africa. Infections are mostly asymptomatic but can cause "Valtice fever", characterized by influenza-like symptoms, mainly in children, with severe cases occasionally causing neurological symptoms. The virus is maintained in an enzootic cycle between small mammals and mosquitoes. Recent and comprehensive studies of vector competence for TAHV are scarce. To fill this gap, and to better understand the transmission cycle of TAHV, we studied ten taxa (Ae. aegypti, Ae. albopictus, Ae. japonicus japonicus, Ae. koreicus, Ae. rusticus, Cx. pipiens biotype pipiens, Cx. torrentium, Cs. morsitans/fumipennis, An. daciae, and An. stephensi) by orally infecting them with TAHV. All taxa were susceptible to TAHV infection. Additionally, the invasive species Ae. albopictus, and Ae. rusticus, a species native to Europe, were able to transmit the virus at 27 ± 5 °C, with transmission efficiencies of 3.3% and 14.3%, respectively. Therefore, it is plausible for TAHV to be transmitted by Ae. albopictus and Ae. rusticus in natural settings in Europe. At a lower temperature of 24 ± 5 °C, infection and transmission decreased in Ae. albopictus. This data will allow future risk models and early warning systems to better predict TAHV transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.